Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: ARALEZ PHARMACEUTICALS CANADA INC
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02454130 | ARALEZ PHARMACEUTICALS CANADA INC | BLEXTEN | Human | Yes | Prescription | 1 | BILASTINE | 20 MG |
Marketed | 02519011 | ARALEZ PHARMACEUTICALS CANADA INC | BLEXTEN | Human | Yes | Prescription | 1 | BILASTINE | 2.5 MG / ML |
Marketed | 02519038 | ARALEZ PHARMACEUTICALS CANADA INC | BLEXTEN | Human | Yes | Prescription | 1 | BILASTINE | 10 MG |
Marketed | 02381680 | ARALEZ PHARMACEUTICALS CANADA INC | CAMBIA | Human | Yes | Prescription | 1 | DICLOFENAC POTASSIUM | 50 MG / SACHET |
Marketed | 00226327 | ARALEZ PHARMACEUTICALS CANADA INC | FIORINAL | Human | Yes | Schedule G (CDSA IV) | 3 | BUTALBITAL | 50 MG |
Marketed | 00176206 | ARALEZ PHARMACEUTICALS CANADA INC | FIORINAL-C 1/2 | Human | Yes | Narcotic (CDSA I) | 4 | ACETYLSALICYLIC ACID | 330 MG |
Marketed | 00176192 | ARALEZ PHARMACEUTICALS CANADA INC | FIORINAL-C 1/4 | Human | Yes | Narcotic (CDSA I) | 4 | ACETYLSALICYLIC ACID | 330 MG |
Marketed | 02359499 | ARALEZ PHARMACEUTICALS CANADA INC | MOVIPREP | Human | Yes | Ethical | 6 | POLYETHYLENE GLYCOL 3350 | 100 G / SACHET |
Cancelled Post Market | 02328232 | ARALEZ PHARMACEUTICALS CANADA INC | PEGALAX | Human | No | OTC | 1 | POLYETHYLENE GLYCOL 3350 | 100 % / W/W |
Marketed | 02279592 | ARALEZ PHARMACEUTICALS CANADA INC | RESULTZ | Human | No | OTC | 1 | ISOPROPYL MYRISTATE | 50 % / W/W |
Marketed | 02496305 | ARALEZ PHARMACEUTICALS CANADA INC | SUVEXX | Human | Yes | Prescription | 2 | SUMATRIPTAN (SUMATRIPTAN SUCCINATE) | 85 MG |
Application information
Related information
Contact us
Version 4.0.3